Skip to main content
Erschienen in: Archives of Dermatological Research 4/2024

01.05.2024 | SHORT REPORT

Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum

verfasst von: Sarah L. Becker, Jorge A. Rios-Duarte, Georgia Mae Morrison, Eric Xia, Arash Mostaghimi, Sonia Himed, Benjamin H. Kaffenberger, Donglin Zhang, Bridget E. Shields, Anna L. Cogen, Alex G. Ortega-Loayza

Erschienen in: Archives of Dermatological Research | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Peristomal pyoderma gangrenosum is an uncommon subtype of pyoderma gangrenosum mainly affecting stoma sites of patients with inflammatory bowel disease. While surgical treatments are often used to assist healing, little is known about the relationship between surgical interventions and the rate of recurrence of peristomal pyoderma gangrenosum. The aim of this study was to identify patient and clinical factors associated with peristomal pyoderma gangrenosum recurrence following surgical intervention. A multi-institutional retrospective case series and literature review was conducted to evaluate patient characteristics and perioperative treatment. Patients of any age with peristomal pyoderma gangrenosum undergoing surgical operations related to their pyoderma gangrenosum or due to another comorbidity were included. Descriptive statistics were used to characterize demographic information. Associations were evaluated using Wilcoxon’s rank-sum test for continuous variables and Fisher’s exact test for categorical data. Thirty-seven cases were included, 78.3% of which had a history of inflammatory bowel disease. Overall, 13 (35.1%) cases experienced recurrence at 30 days. There was no significant association identified between patient demographics, stoma location, surgical intervention, or perioperative treatment with rate of recurrence at 30 days post-operation. While no clinical risk factors or treatments were associated with recurrence, our work underscores the importance of a multidisciplinary approach to this disease to address gastrointestinal, dermatologic, and surgical components of treatment.
Literatur
2.
Zurück zum Zitat Ruocco E et al (2009) Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 23(9):1008–1017CrossRefPubMed Ruocco E et al (2009) Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 23(9):1008–1017CrossRefPubMed
3.
Zurück zum Zitat Afifi L et al (2018) Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol 78(6):1195-1204.e1CrossRefPubMed Afifi L et al (2018) Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol 78(6):1195-1204.e1CrossRefPubMed
4.
Zurück zum Zitat Hughes AP, Jackson JM, Callen JP (2000) Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284(12):1546–1548CrossRefPubMed Hughes AP, Jackson JM, Callen JP (2000) Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284(12):1546–1548CrossRefPubMed
5.
Zurück zum Zitat Kiran RP et al (2005) Management of peristomal pyoderma gangrenosum. Dis Colon Rectum 48(7):1397–1403CrossRefPubMed Kiran RP et al (2005) Management of peristomal pyoderma gangrenosum. Dis Colon Rectum 48(7):1397–1403CrossRefPubMed
6.
Zurück zum Zitat Sheldon DG et al (2000) Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 135(5):564–569CrossRefPubMed Sheldon DG et al (2000) Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 135(5):564–569CrossRefPubMed
7.
Zurück zum Zitat Flynn RL et al (2019) Rare presentation of postsurgical pyoderma gangrenosum presenting as necrotizing soft tissue infection. Adv Skin Wound Care 32(11):507–511CrossRefPubMedPubMedCentral Flynn RL et al (2019) Rare presentation of postsurgical pyoderma gangrenosum presenting as necrotizing soft tissue infection. Adv Skin Wound Care 32(11):507–511CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Franco S et al (2011) Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum. Inflamm Bowel Dis 17(8):E111–E112CrossRefPubMed Franco S et al (2011) Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum. Inflamm Bowel Dis 17(8):E111–E112CrossRefPubMed
9.
Zurück zum Zitat Barbosa NS et al (2016) Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. J Am Acad Dermatol 75(5):931–939CrossRefPubMed Barbosa NS et al (2016) Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. J Am Acad Dermatol 75(5):931–939CrossRefPubMed
10.
Zurück zum Zitat Wu X-R et al (2013) Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis 7(5):e171–e177CrossRefPubMed Wu X-R et al (2013) Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis 7(5):e171–e177CrossRefPubMed
12.
Zurück zum Zitat van Koperen PJ et al (2009) Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg 96(6):675–679CrossRefPubMed van Koperen PJ et al (2009) Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg 96(6):675–679CrossRefPubMed
13.
Zurück zum Zitat Lyon CC et al (2000) Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 42(6):992–1002CrossRefPubMed Lyon CC et al (2000) Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 42(6):992–1002CrossRefPubMed
14.
Zurück zum Zitat Panganiban RP et al (2023) Pyoderma gangrenosum is associated with increased risk of inflammatory pouch-related complications: a retrospective cohort study. Crohns Colitis 360 5(3):otad024CrossRefPubMedPubMedCentral Panganiban RP et al (2023) Pyoderma gangrenosum is associated with increased risk of inflammatory pouch-related complications: a retrospective cohort study. Crohns Colitis 360 5(3):otad024CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Xia FD et al (2018) Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 78(2):310-314.e1CrossRefPubMed Xia FD et al (2018) Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 78(2):310-314.e1CrossRefPubMed
Metadaten
Titel
Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum
verfasst von
Sarah L. Becker
Jorge A. Rios-Duarte
Georgia Mae Morrison
Eric Xia
Arash Mostaghimi
Sonia Himed
Benjamin H. Kaffenberger
Donglin Zhang
Bridget E. Shields
Anna L. Cogen
Alex G. Ortega-Loayza
Publikationsdatum
01.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 4/2024
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-02826-3

Weitere Artikel der Ausgabe 4/2024

Archives of Dermatological Research 4/2024 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.